Alignment Healthcare Q3 revenue beats estimates on growth in health plan membership

Alignment Healthcare

30/10/2025 20:23

Overview

Alignment Healthcare Q3 revenue grows 43.5% yr/yr, beating analyst expectations

Company raises full-year outlook across all key metrics

Outlook

Alignment Healthcare sees full-year revenue outlook to $3.931 bln - $3.946 bln

Company expects Q4 revenue between $995 mln and $1.010 bln

Alignment Healthcare forecasts full-year adjusted EBITDA of $90 mln to $98 mln

Result Drivers

MEMBERSHIP GROWTH - Health plan membership increased by 25.9% yr/yr, contributing to revenue growth

HIGH PLAN RATINGS - 100% of members in plans rated 4 stars or higher for second consecutive year

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
Beat
$993.70 mln
$981.35 mln (11 Analysts)
Q3 EPS
$0.02
Q3 Net Income
$3.72 mln
Q3 Adjusted EBITDA
$32.43 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the managed healthcare peer group is "buy"

Wall Street's median 12-month price target for Alignment Healthcare Inc is $20.00, about 8.9% above its October 29 closing price of $18.21

Press Release: ID:nGNX162tVk

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)